The study found no increased risk of infections or overdoses and a decline in healthcare costs unrelated to primary care or outpatient medications after a year.
The potential for a weak flu shot uptake could combine with a difficult flu season and stress the health-care system further, says Danielle Paes, Chief Pharmacist Officer of the CPhA